Molecule Safely Eases Dyskinesia Tied to Levodopa in Primate Model

Molecule Safely Eases Dyskinesia Tied to Levodopa  in Primate Model

313549

Molecule Safely Eases Dyskinesia Tied to Levodopa in Primate Model

A newly discovered oral molecule, called PD13R, significantly lessened levodopa-induced dyskinesia, its involuntary and jerky movements, while maintaining the therapy’s benefits in a non-human primate model of Parkinson’s disease. Notably, in contrast to Gocovri (amantadine) — an approved therapy to treat levodopa-induced dyskinesia — PD13R did not affect the animals’ sleep, suggesting this new molecule may be a safer as well as effective in treating dyskinesia, the researchers noted. “We were very excited to see the robust…

You must be logged in to read/download the full post.